The Goldman Sachs Group, Inc. 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 3:54 pm Purchase | 2023-05-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | GOLDMAN SACHS GROUP INC GS | 3,653,782 5.400% | 3,653,782 (New Position) | Filing |